Clinical trials
Completed Phase 3 Lung Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
149 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 6 |
| 2001 | 10 |
| 2002 | 6 |
| 2003 | 3 |
| 2004 | 6 |
| 2005 | 9 |
| 2006 | 9 |
| 2007 | 8 |
| 2008 | 5 |
| 2009 | 6 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 8 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 6 |
| 2021 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 149 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alliance for Clinical Trials in Oncology | 14 |
| Radiation Therapy Oncology Group | 6 |
| Bristol-Myers Squibb | 5 |
| European Organisation for Research and Treatment of Cancer - EORTC | 5 |
| NCIC Clinical Trials Group | 5 |
| AstraZeneca | 4 |
| Genentech, Inc. | 4 |
| Sanofi | 4 |
| University College, London | 4 |
| Case Comprehensive Cancer Center | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 149 |
| Carcinoma, Non-Small-Cell Lung | 80 |
| Adenocarcinoma of Lung | 15 |
| Small Cell Lung Carcinoma | 13 |
| Breast Neoplasms | 9 |
| Neoplasms | 7 |
| Pain | 6 |
| Neoplasm Metastasis | 5 |
| Prostatic Neoplasms | 5 |
| Adenocarcinoma, Bronchiolo-Alveolar | 4 |
Trials
Showing 1 to 25 of 149. Each trial links to its page on Pharma Observatory.
49 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.